Viekira Pak​​

Kathryn Dzintars, Pharm.D., BCPS
Viekira Pak​​ is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Viekira Pak: combination pack of four medications.
    • Ombitasvir/paritaprevir/ritonavir and dasabuvir
    • Indicated for treatment of hepatitis C virus (HCV) genotype 1 (1a or 1b) infection with or without the addition of ribavirin
  • Viekira Pak has been studied in patients with HIV co-infection, liver transplant recipients and those with compensated cirrhosis and/or mild hepatic impairment

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Viekira Pak: combination pack of four medications.
    • Ombitasvir/paritaprevir/ritonavir and dasabuvir
    • Indicated for treatment of hepatitis C virus (HCV) genotype 1 (1a or 1b) infection with or without the addition of ribavirin
  • Viekira Pak has been studied in patients with HIV co-infection, liver transplant recipients and those with compensated cirrhosis and/or mild hepatic impairment

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: March 2, 2017